Intralesional treatment with recombinant interferon beta is an effective alternative for the treatment of basal cell carcinoma. Double-blind, placebo-controlled study;Doogniskowe podawanie rekombinantowego interferonu beta. Skuteczna alternatywa w leczeniu basalioma (wyniki podwojnie slepej proby)

Przeglad Dermatologiczny

Volumn 84, Issue 3, 1997, Pages 259-263

  Rogozinski, T T ^a   Jablonska, S ^a   Brzoska, J ^a   Michalska, I ^a   Wohr, C ^a   Gaus, W ^a  

^a Klinika Dermatologiczna Medical University of Warsaw   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; PLACEBO; RECOMBINANT BETA INTERFERON;

ARTICLE; BASAL CELL CARCINOMA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERANCE; HISTOLOGY; HUMAN; INFLAMMATION;

EID: 0030772626     PISSN: 00332526     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)